Hoth Therapeutics, Inc.
HOTH
$0.8687
-$0.021-2.36%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.06M | 1.23M | 1.08M | 1.59M | 783.20K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.38M | 2.13M | 1.65M | 2.05M | 1.96M |
| Operating Income | -2.38M | -2.13M | -1.65M | -2.05M | -1.96M |
| Income Before Tax | -2.38M | -2.13M | -1.63M | -2.04M | -1.96M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.38M | -2.13M | -1.63M | -2.04M | -1.96M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.38M | -2.13M | -1.63M | -2.04M | -1.96M |
| EBIT | -2.38M | -2.13M | -1.65M | -2.05M | -1.96M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.33 | -0.31 | -0.24 | -0.46 | -0.45 |
| Normalized Basic EPS | -0.20 | -0.19 | -0.15 | -0.29 | -0.28 |
| EPS Diluted | -0.33 | -0.31 | -0.24 | -0.46 | -0.45 |
| Normalized Diluted EPS | -0.20 | -0.19 | -0.15 | -0.29 | -0.28 |
| Average Basic Shares Outstanding | 7.31M | 6.90M | 6.88M | 4.40M | 4.36M |
| Average Diluted Shares Outstanding | 7.31M | 6.90M | 6.88M | 4.40M | 4.36M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |